Document is current
Any future updates will be listed below
-
Authors
Sands, Jacob
Schoenfeld, Adam
Schwarzenberger, Paul
delCorral, Christopher
Geng, Dong
Yun, Zhong
Wang, Chaun
Amato, Gianni
Vahora, Sahista
Pacaud, Lida
Hao, Zhonglin
Chiappori, Alberto
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct05680922 at ClinicalTrials.govnct05680922 at ClinicalTrials.govDocuments that mention this clinical trial
702 Phase 1 study of DLL3-directed chimeric antigen receptor T-cells in subjects with extensive stage small cell lung cancer
https://doi.org/10.1136/jitc-2023-sitc2023.0702
New developments in immunotherapy for SCLC
https://doi.org/10.1136/jitc-2024-009667
Documents that mention this clinical trial
702 Phase 1 study of DLL3-directed chimeric antigen receptor T-cells in subjects with extensive stage small cell lung cancer
https://doi.org/10.1136/jitc-2023-sitc2023.0702
New developments in immunotherapy for SCLC
https://doi.org/10.1136/jitc-2024-009667
- License Information
